Technical Analysis for ATRA - Atara Biotherapeutics, Inc.

Grade Last Price % Change Price Change
grade B 39.29 0.28% 0.11
ATRA closed up 0.28 percent on Tuesday, March 19, 2019, on 53 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ATRA trend table...

Date Alert Name Type % Chg
Mar 19 NR7 Range Contraction 0.00%
Mar 18 Crossed Above 200 DMA Bullish 0.28%
Mar 18 Crossed Above 20 DMA Bullish 0.28%
Mar 15 Fell Below 200 DMA Bearish 2.48%
Mar 15 Fell Below 20 DMA Bearish 2.48%
Mar 14 Multiple of Ten Bearish Other 0.80%
Mar 14 Outside Day Range Expansion 0.80%
Mar 13 MACD Bullish Signal Line Cross Bullish -3.35%
Mar 13 Multiple of Ten Bullish Other -3.35%
Mar 13 Up 3 Days in a Row Strength -3.35%

Older signals for ATRA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of muscle wasting conditions and oncology. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. The company is also developing STM 434, a targeted therapy for ovarian cancer and other solid tumors; and a pipeline of product candidates that are in preclinical development. Atara Biotherapeutics, Inc. was founded in 2012 and is headquartered in Brisbane, California.
Medicine Biopharmaceutical Clinical Medicine Drugs Solid Tumors Ovarian Cancer End Stage Renal Disease Targeted Therapy
Is ATRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 54.45
52 Week Low 27.85
Average Volume 425,025
200-Day Moving Average 38.4317
50-Day Moving Average 37.3752
20-Day Moving Average 38.3195
10-Day Moving Average 38.303
Average True Range 1.8497
ADX 13.12
+DI 27.1072
-DI 20.7696
Chandelier Exit (Long, 3 ATRs ) 36.4209
Chandelier Exit (Short, 3 ATRs ) 40.4091
Upper Bollinger Band 41.3208
Lower Bollinger Band 35.3182
Percent B (%b) 0.66
BandWidth 15.664609
MACD Line 0.3652
MACD Signal Line 0.2792
MACD Histogram 0.086
Fundamentals Value
Market Cap 1.2 Billion
Num Shares 30.6 Million
EPS -3.33
Price-to-Earnings (P/E) Ratio -11.80
Price-to-Sales 0.00
Price-to-Book 1.83
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.72
Resistance 3 (R3) 40.79 40.39 40.48
Resistance 2 (R2) 40.39 40.03 40.35 40.40
Resistance 1 (R1) 39.84 39.80 39.64 39.77 40.32
Pivot Point 39.44 39.44 39.34 39.40 39.44
Support 1 (S1) 38.89 39.08 38.69 38.82 38.26
Support 2 (S2) 38.49 38.85 38.45 38.18
Support 3 (S3) 37.94 38.49 38.10
Support 4 (S4) 37.87